ɬ﷬

Journal News

Scientists find unexpected correlation between age and HDL-C levels

Jessica Desamero
June 3, 2025

Coronary heart disease, or CHD, is a type of heart disease in which coronary arteries can’t deliver enough oxygen-rich blood to the heart, causing chest pain, shortness of breath and potentially a heart attack. High-density lipoprotein cholesterol, or HDL-C, also known as “good” cholesterol, levels are a risk indicator of CHD. Naturally high HDL-C levels reduce the risk of CHD, while low HDL-C levels increase this risk.

In a recent Journal of Lipid Research , researchers determined how various factors, such as age, physical activity and childbirth, predict HDL-C serum concentration in a large, diverse cohort of adults. This multicenter study is one of the few to analyze HDL-C over an extended period, over 30 years, rather than only one time point.

Scientific Animations

The Coronary Artery Risk Development in Young Adults study, or , began in 1985 with a group of 5,115 Black and white men and women, aged 18–30 years, across multiple U.S. sites. and his team led the coordinating center for the study at the University of Alabama at Birmingham. CARDIA examines the risk factors of CHD. Since then, Shikany has expanded the study to examine factors associated with HDL-C.

Participants receive tests and respond to questionnaires every five years to measure these factors. Shikany and his team then examine patterns in physical measurements, lifestyle factors, behavioral and psychological variables, medical and family history and blood concentrations of relevant substances. They then performed statistical regression analyses on the data. In their study, the team tested additional variables associated with HDL-C, including menopause status, hormone therapy and use of prescription drugs that lower cholesterol levels. Shikany said previous studies rarely examined these variables.

“I started noticing over the years that the HDL-C (serum levels) in CARDIA in men and women has been rising since year 15,” Shikany said. “(T)hat just piqued my interest.”

Shikany said this observation puzzled him because most participants showed higher weights, a characteristic usually associated with lower HDL-C levels.

The team observed that HDL-C levels positively correlated with age, alcohol intake, hormone therapy and birth control use and physical activity. Moreover, they found that individuals who had given birth had lower HDL-C levels than those who had not, with an even stronger correlation amongst those that birthed three or more children. Other factors associated with lower HDL-C concentrations include smoking and BMI.

Several questions remain, as the researchers did not identify one main factor driving the increased HDL-C levels. Shikany said age may be the driving factor, however, more research is needed to confirm that hypothesis.

Future directions will explore additional factors that may impact HDL-C levels and examine details of patient HDL-C, such as subtypes and functionality.

CARDIA is ongoing, and its duration will soon reach 40 years. Shikany said he hopes that the study will continue for many more years, allowing researchers to determine additional factors that influence cholesterol levels.

“We’ve always had very good retention; about 70% of the surviving cohorts come back for each exam,” Shikany said. “It’s really remarkable and shows their dedication, so we want to always express our appreciation.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Jessica Desamero

Jessica Desamero is a graduate of the biochemistry Ph.D. program at the City University of New York Graduate Center. She volunteers with the science outreach organization BioBus, and she is an ASBMB Today volunteer contributor.

Related articles

From the Journals: JLR
Vanshika Patel
Meet Robert Helsley
Christopher Radka
From the journals: JLR
Sephra Rampersad
From the journals: JLR
Nivedita Uday Hegdekar

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
Feature

Using 'nature’s mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer’s code through functional connections
News

Cracking cancer’s code through functional connections

July 2, 2025

A machine learning–derived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.

Gaze into the proteomics crystal ball
In-person Conference

Gaze into the proteomics crystal ball

July 1, 2025

The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17–21 in Cambridge, Massachusetts.